Ablative Radiotherapy in Patients with Large Volume Liver Metastases and in Those with Prior Liver Directed Therapies: An Analysis of Safety and Local Control
Jared Bassmann(Memorial Sloan Kettering Cancer Center), C. Hajj(Memorial Sloan Kettering Cancer Center), Marsha Reyngold(Memorial Sloan Kettering Cancer Center), P.B. Romesser(Memorial Sloan Kettering Cancer Center), Lillian A. Boe(Memorial Sloan Kettering Cancer Center), Santiago Chahwan(Memorial Sloan Kettering Cancer Center), A. Wei(Memorial Sloan Kettering Cancer Center), C.H. Crane(Memorial Sloan Kettering Cancer Center), Maria El Homsi(Memorial Sloan Kettering Cancer Center), Haim Azhari(Memorial Sloan Kettering Cancer Center), Nayoung Kim(Sogang University), William R. Jarnagin(Memorial Sloan Kettering Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 27, 2024
Cited by 0
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Progressive plasticity during colorectal cancer metastasis
|Nature|2024|149